ofloxacin has been researched along with Infections, Staphylococcal Skin in 8 studies
Ofloxacin: A synthetic fluoroquinolone antibacterial agent that inhibits the supercoiling activity of bacterial DNA GYRASE, halting DNA REPLICATION.
9-fluoro-3-methyl-10-(4-methylpiperazin-1-yl)-7-oxo-2,3-dihydro-7H-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxylic acid : An oxazinoquinoline that is 2,3-dihydro-7H-[1,4]oxazino[2,3,4-ij]quinolin-7-one substituted by methyl, carboxy, fluoro, and 4-methylpiperazin-1-yl groups at positions 3, 6, 9, and 10, respectively.
ofloxacin : A racemate comprising equimolar amounts of levofloxacin and dextrofloxacin. It is a synthetic fluoroquinolone antibacterial agent which inhibits the supercoiling activity of bacterial DNA gyrase, halting DNA replication.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Oral levofloxacin was compared to oral ciprofloxacin in a Staphylococcus aureus subcutaneous abscess model in rabbits." | 7.70 | Comparison of efficacies of oral levofloxacin and oral ciprofloxacin in a rabbit model of a staphylococcal abscess. ( Amaratunga, D; Barrett, JF; Fernandez, J; Frosco, M; Licata, L, 1999) |
| "Oral levofloxacin was compared to oral ciprofloxacin in a Staphylococcus aureus subcutaneous abscess model in rabbits." | 3.70 | Comparison of efficacies of oral levofloxacin and oral ciprofloxacin in a rabbit model of a staphylococcal abscess. ( Amaratunga, D; Barrett, JF; Fernandez, J; Frosco, M; Licata, L, 1999) |
| "Ofloxacin, a new pyridone-carboxylic acid derivative, was evaluated in descending nephritis and subcutaneous abscess models with Staphylococcus aureus in mice in comparison with norfloxacin." | 3.67 | Chemotherapeutic efficacy of ofloxacin on renal and subcutaneous infection models with Staphylococcus aureus in mice. ( Fujimoto, T; Katami, K; Osada, Y; Sato, M; Tachizawa, H; Tsumura, M; Une, T, 1986) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (12.50) | 18.7374 |
| 1990's | 3 (37.50) | 18.2507 |
| 2000's | 3 (37.50) | 29.6817 |
| 2010's | 1 (12.50) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Trad, S | 1 |
| Saadoun, D | 1 |
| Barete, S | 1 |
| Frances, C | 1 |
| Piette, JC | 1 |
| Wechsler, B | 1 |
| Farrell, DJ | 1 |
| Turner, LL | 1 |
| Castanheira, M | 1 |
| Jones, RN | 1 |
| Fish, DN | 1 |
| Sesso, R | 1 |
| Parisio, K | 1 |
| Dalboni, A | 1 |
| Rabelo, T | 1 |
| Barbosa, D | 1 |
| Cendoroglo, M | 1 |
| Pignatari, A | 1 |
| Draibe, S | 1 |
| Ajzen, H | 1 |
| Nishijima, S | 1 |
| Namura, S | 1 |
| Mitsuya, K | 1 |
| Asada, Y | 1 |
| Fernandez, J | 1 |
| Barrett, JF | 1 |
| Licata, L | 1 |
| Amaratunga, D | 1 |
| Frosco, M | 1 |
| Yamakawa, T | 1 |
| Mitsuyama, J | 1 |
| Hayashi, K | 1 |
| Fujimoto, T | 1 |
| Sato, M | 1 |
| Katami, K | 1 |
| Osada, Y | 1 |
| Tsumura, M | 1 |
| Tachizawa, H | 1 |
| Une, T | 1 |
1 review available for ofloxacin and Infections, Staphylococcal Skin
| Article | Year |
|---|---|
Levofloxacin: update and perspectives on one of the original 'respiratory quinolones'.
Topics: Animals; Drug Resistance, Microbial; Humans; Levofloxacin; Ofloxacin; Quinolones; Respiratory Tract | 2003 |
1 trial available for ofloxacin and Infections, Staphylococcal Skin
| Article | Year |
|---|---|
Effect of sodium fusidate and ofloxacin on Staphylococcus aureus colonization and infection in patients on continuous ambulatory peritoneal dialysis.
Topics: Administration, Oral; Administration, Topical; Adult; Catheters, Indwelling; Female; Fusidic Acid; H | 1994 |
6 other studies available for ofloxacin and Infections, Staphylococcal Skin
| Article | Year |
|---|---|
[Necrotizing folliculitis in Behçet's disease].
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Anti-Infective Agents, Local; Bacterial Toxins; Behcet | 2009 |
Activity of JNJ-Q2 against Staphylococcus aureus isolated from patients with acute bacterial skin and skin-structure infection obtained during a Phase 2 clinical trial.
Topics: Anti-Bacterial Agents; Aza Compounds; Drug Resistance, Bacterial; Fluoroquinolones; Humans; Levoflox | 2012 |
The incidence of isolation of methicillin-resistant Staphylococcus aureus (MRSA) strains from skin infections during the past three years (1989-1991).
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Bacteriophage Typing; Child; Cilastatin; Coagulase; Colo | 1993 |
Comparison of efficacies of oral levofloxacin and oral ciprofloxacin in a rabbit model of a staphylococcal abscess.
Topics: Abscess; Animals; Anti-Infective Agents; Area Under Curve; Ciprofloxacin; Female; Levofloxacin; Micr | 1999 |
In vitro and in vivo antibacterial activity of T-3912, a novel non-fluorinated topical quinolone.
Topics: Animals; Anti-Infective Agents; Clindamycin; Colony Count, Microbial; DNA Topoisomerase IV; Drug Res | 2002 |
Chemotherapeutic efficacy of ofloxacin on renal and subcutaneous infection models with Staphylococcus aureus in mice.
Topics: Abscess; Animals; Anti-Bacterial Agents; Autoradiography; Disease Models, Animal; Kinetics; Male; Mi | 1986 |